Benzamidi

TMB is an excellent colorimetric substrate for detection of horseradish peroxidase labelled probes and is used with peroxidase and peroxidase coupled systems, particularly in ELISA techniques. It produces a soluble end product, which is blue in color and can be read spectrophotometrically. TMB has also been used in the quantitative determination of hemoglobin and in cytochemical staining for peroxidase. TMB is a hepatitis B antigen.

3-Amino-4-methoxybenzamide (3AMB) is a transcriptional regulator that inhibits the expression of genes encoding for the synthesis of aminoglycoside antibiotics. 3AMB binds to DNA, forming a heteromer with the transcription factor HANATX, which prevents RNA polymerase from binding to DNA. This in turn inhibits gene expression and bacterial growth. 3AMB has been shown to trigger diabetic neuropathy by inhibiting xylitol dehydrogenase, an enzyme required for neuron protection against oxidative stress. The drug also has a high affinity for nucleophiles and can bind to various substrates such as sulfhydryl groups or hydroxyl groups.

4-Bromo-2-chloroaniline (4BCA) is an exciplex that forms in the presence of hydrogen peroxide and chloride ions. It is unreactive with fluconazole and other related molecules, but is able to photoreduce hydrogen peroxide. The molecular mechanism of 4BCA is a result of its ability to form a covalent bond with DNA containing pyrimidine bases. This reaction results in the formation of pyrimidine dimers, which can lead to cell death through the inhibition of DNA synthesis and repair. 4BCA has been shown to be effective against cancer cells at high concentrations, but does not affect healthy cells. The effectiveness against cancer cells may be due to the fact that this exciplex reacts with uv irradiation and irradiation, which leads to a higher concentration of reactive oxygen species (ROS).

2-Iodoaniline is a nucleophilic compound that reacts with electrophiles to form alkyl halides. It is used in the synthesis of β-aminoesters, which are used as γ-secretase inhibitors for the treatment of Alzheimer's disease. 2-Iodoaniline has been shown to be an effective inhibitor of protozoan parasites, such as Leishmania major and Trypanosoma cruzi, by blocking the conversion of pyruvate to oxaloacetate via enzymatic action. The chloride ion stabilizes the phenoxide anion intermediate and facilitates nucleophilic attack on the aromatic ring. 2-Iodoaniline has also been shown to be a competitive inhibitor of acylation reactions, due to its ability to bind covalently with acyl groups and inhibit their formation.

3,4,5-Trihydroxybenzamide (THB) is an active agent that inhibits the synthesis of prostaglandin J2. It has been shown to inhibit the uptake of fatty acids in rat liver cells by blocking fatty acid binding proteins. THB has also been shown to inhibit the chemical structures of nitro and epidermal growth factor. 3,4,5-Trihydroxybenzamide can be used as a cancer treatment by inhibiting the growth and spread of cancer cells. This drug is also believed to have a protective effect on the skin by reducing inflammation and increasing cell proliferation.
THB is currently being researched for its ability to suppress histone proteins and growth factors such as HGF or EGF in human HL60 cells.

4-(1-Adamantyl)aniline is a monomer with electron-deficient properties. It can be synthesized from 1-adamantanol and trifluoroacetic acid, followed by hydrolysis to remove the trifluoromethyl group. 4-(1-Adamantyl)aniline has been shown to have high cytotoxicity against tumor cells in vitro. This compound also inhibits the production of necrosis factor, an inflammatory cytokine that plays an important role in many pathological processes, such as septic shock and acute respiratory distress syndrome.

4,5-Dichloro-1,2-phenylenediamine is a cytotoxic agent that can inhibit the enzymes urea amidolyase and fatty acid synthase in tissue culture. This compound also inhibits the production of urea nitrogen and fatty acids in human serum. 4,5-Dichloro-1,2-phenylenediamine may be useful as a cancer treatment because it has been shown to cause leukemia cell death as well as inhibition of t-cell proliferation. The drug may also induce apoptosis by inhibiting DNA synthesis through its reaction with benzimidazole compounds. The basic structure of 4,5-Dichloro-1,2-phenylenediamine is similar to protocatechuic acid and malignant brain tumor cells.